Portfolio
Our focus is to help founders go further
RYSE backs visionary founders who are driving transformative change in HealthTech, tackling global healthcare challenges such as an ageing population, the rise of chronic diseases, and the demand for more efficient care delivery.
Our focus on tech-enabled health solutions — across digital diagnostics, digital therapeutics, medical devices and data and discovery platforms — all designed to make healthcare more affordable, accessible, and impactful. With deep expertise in cardiovascular health, metabolic disorders, oncology, mental health, women’s health, and health AI, RYSE is committed to empowering innovations that redefine the future of healthcare.
Fund Investments
RYSE launched the Special Opportunities HealthTech Fund in January 2024 to invest in innovate HealthTech solutions
that improve access to and quality of care.
Braingaze
Braingaze develops cutting-edge eye-tracking technology to provide early and accurate detection of neurodevelopmental and mental health disorders, including ADHD and autism. Their mission is to revolutionize diagnostics and improve patient outcomes through non-invasive solutions.
Curio
Curio delivers digital therapeutics designed to support women’s health, focusing on solutions for postpartum depression and other mental health challenges. Their goal is to empower women with accessible, evidence-based tools for mental wellness.
Ten63
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases.
Second Nature
Make losing weight feel Second Nature. Their app uses behavioural science to retrain your mind to make healthy choices automatically, so these stick in the long run.
Syndicate Investments
Skin Analytics specialises in cancer screening for melanoma and non-melanoma skin cancers. The company invested heavily in their AI technology with the potential to revolutionise the process of diagnosis and management of skin cancer and has validated their proprietary technology in two large research studies.
Skin Analytics
“RYSE have given us excellent access to leading NHS initiatives, those behind them, as well as the strategic support needed to get our technology to the point it will positively impact patients and the healthcare service".
Neil Daly, Founder of Skin Analytics
Knokcare is a simplified telemedicine solution for virtual consultations through a combination of triage, scheduling, record keeping, and integration with healthcare providers.
Knokcare
“RYSE gives us great access to UK based clinical and technology talent. We are excited to work with RYSE given their previous experience supporting companies with medical insurer and corporate distribution channels”.
José Bastos, Co-founder of Knokcare
Log my Care is a care management software that is improving care coordination and communication in social care. Specifically, it has been designed for and by carers.
Log My Care
“RYSE provide access to invaluable healthcare providers and payors. We look forward to working with RYSE in the next phase of our growth and distribution in order to bring social care into the 21st century”.
Sam Hussain, Founder of Log my Care
MediShout provides mobile and web-based healthcare reporting software to quickly, and accurately, report logistical issues to increase the quality and reduce the cost of healthcare delivery.
MediShout
“RYSE has provided us with a first seed round of funding to develop our reach into the broader healthcare market. We are excited to work with them - to address some of the key issues in our healthcare supply chain - for the benefit of our valued healthcare providers and patients”.
Dr Ashish Kalraiya, Founder of MediShout
Oto builds digital therapeutics that allows instant access to an evidence-based therapy app for tinnitus – a debilitating condition affecting 1 in 8 people. Their vision is simple: a world where everyone can live without intrusion from tinnitus.
Oto
“Tinnitus is a condition that has long been underfunded and underserved. RYSE’s healthcare and funding network will help us improve tinnitus management for millions around the world”.
Dr Edmund Farrar, Co-founder of Oto